Henssen, D.; Rullmann, M.; Schildan, A.; Striepe, S.; Schürer, M.; Feraco, P.; Scherlach, C.; Jähne, K.; Stassart, R.; Sabri, O.;
et al. Retrospective Evaluation of Baseline Amino Acid PET for Identifying Future Regions of Tumor Recurrence in High-Grade Glioma Patients. Cancers 2025, 17, 1986.
https://doi.org/10.3390/cancers17121986
AMA Style
Henssen D, Rullmann M, Schildan A, Striepe S, Schürer M, Feraco P, Scherlach C, Jähne K, Stassart R, Sabri O,
et al. Retrospective Evaluation of Baseline Amino Acid PET for Identifying Future Regions of Tumor Recurrence in High-Grade Glioma Patients. Cancers. 2025; 17(12):1986.
https://doi.org/10.3390/cancers17121986
Chicago/Turabian Style
Henssen, Dylan, Michael Rullmann, Andreas Schildan, Stephan Striepe, Matti Schürer, Paola Feraco, Cordula Scherlach, Katja Jähne, Ruth Stassart, Osama Sabri,
and et al. 2025. "Retrospective Evaluation of Baseline Amino Acid PET for Identifying Future Regions of Tumor Recurrence in High-Grade Glioma Patients" Cancers 17, no. 12: 1986.
https://doi.org/10.3390/cancers17121986
APA Style
Henssen, D., Rullmann, M., Schildan, A., Striepe, S., Schürer, M., Feraco, P., Scherlach, C., Jähne, K., Stassart, R., Sabri, O., Seidel, C., & Hesse, S.
(2025). Retrospective Evaluation of Baseline Amino Acid PET for Identifying Future Regions of Tumor Recurrence in High-Grade Glioma Patients. Cancers, 17(12), 1986.
https://doi.org/10.3390/cancers17121986